alentemol

N/A

Report date: 2025/04/24 16:17:11
NME

Base Information

Drug Namealentemol
Drug Alias Namealentemol hydrobromideU-68553B
ClassificationSmall molecules
Mechanisms of ActionDopamine D2 receptor antagonistsSerotonin 2 (5-HT2) receptor antagonists
TargetsSerotonin 2a (5-HT2a) receptorDopamine D2 receptorSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsSchizophreniaPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia & Upjohn Co
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia & Upjohn Co
Active IndicationsN/A
Inactive IndicationsSchizophreniaPsychotic Disorders

Other Information

ATC CodeN/A
Related LinksN/A